Levores

Levores

levofloxacin

Manufacturer:

Novell Pharma

Distributor:

DKLL

Marketer:

Genemax Healthcare
Concise Prescribing Info
Contents
Levofloxacin hemihydrate
Indications/Uses
Community-acquired pneumonia, including multidrug-resistant strains of S. pneumoniae. Nosocomial pneumonia, chronic bronchitis (acute bacterial exacerbation), acute bacterial sinusitis, prostatitis, UTI, acute pyelonephritis, skin or skin structure infection. Reduce incidence or disease progression of inhalational anthrax (post-exposure).
Dosage/Direction for Use
250-500 mg. Severe or complicated infections 750 mg 24-hrly for 7-14 days. Renal impairment CrCl <50 mL/min Dosage adjustment is required.
Contraindications
Hypersensitivity to levofloxacin or other quinolones.
Special Precautions
Increased risk of tendon inflammation &/or rupture w/ concurrent corticosteroids, organ transplant recipients, patient >60 yr. CNS effects may occur. Rarely, increased potential for seizures w/ concomitant NSAID therapy. Avoid excessive sunlight. Exacerbation of myasthenia gravis w/ quinolones. Childn <18 yr is only recommended for systemic use for prevention of inhalational anthrax.
Adverse Reactions
Nausea, diarrhea, constipation, headache, insomnia, dizziness, inj site reaction.
Drug Interactions
Avoid concomitant use w/ artemether, BCG, dronedarone, lumefantrine, nilotinib, pimozide, quetiapine, quinine, tetrabenazine, thioridazine, toremifene, vandetanib, vemurafenib, ziprasidone.
MIMS Class
ATC Classification
J01MA12 - levofloxacin ; Belongs to the class of fluoroquinolones. Used in the systemic treatment of infections.
Presentation/Packing
Form
Levores infusion 500 mg/100 mL
Packing/Price
100 mL x 1's;1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in